Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals. Palliative care is not well-integrated in Healthcare;thcare delivery. Why not? And what can be done to improve on this? Listen to an amazing physician, person,
At the Oncology Clinical Pathways Congress, I sit down with Robin T Zon, MD, FACP, FASCO; Lee Schwartzberg, MD, FACP; and Tom Valuck, MD, JD, MHSA, to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
Sayed Tabatabai, MD, a full-time nephrologist and avid writer emerged as a social media sensation when he started sharing humanistic stories in medicine based on his own experience as a physician but also with his own family members. Sayed humanizes and beautifies the patient experience through a variety of written anecdotes in Twitter threads and
I attended the annual clinical pathways congress held in Boston in October 2019 and while there, I made my rounds, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback. So much fun, especially that it was in Boston 🙂
There is so much debate about clinical pathways. Some propose that they are an excellent way to reduce variability in clinical care and reduce cost, but others contend that they take away from the clinical judgment and bind physicians into algorithms that do not represent all the patients they care for. To discuss the pros
The amazing and inspiring Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, former Physician-in-Chief of MSKCC, and someone who has held way too many national titles to count, debated with me some of the ideas laid out in his book, “The Death of Cancer,” most notably the utility
Mark A Lewis, MD, director of GI oncology, Intermountain Healthcare, spoke with me on how to classify the AYA patient population; he explained the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier. But, did you know that you can be considered an adolescent
Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America and former Senior Advisor to President Obama in the White House, shares with me his unique experience of combining the clinical health care discipline with business and policy to help patients on a population level. I even ask Pat about the CTCA
the award-winning hematologist and a medical oncologist who hosted Outspoken Oncology, a podcast featuring candid discussions of the most pressing, and often controversial, medical topics. Combining his background in cancer research and health care advocacy, Dr. Nabhan brings a unique and powerful perspective to current medical events.
